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ABSTRACT 
Aims:  The traditional serrated adenoma (TSA) is the least common subtype of serrated colorectal 
polyp. Large protuberant lesions are easily recognized, however, the origins of TSAs are not known 
and early forms have not been described.  Some large TSAs present with a flat “shoulder” component 
surrounding the central protuberant component.  We hypothesized that small polyps with the same 
histology as these “shoulder” regions may represent early TSAs.   
Methods and results:  We collected 70 small (< 10mm) polyps that may represent early TSAs based on 
typical TSA cytology covering the luminal surface. We also identified 12 large TSAs with a “shoulder” 
component resembling these small polyps. The study polyps patients had a mean age of 58 years, 
54% were female, had a mean 4.1mm diameter and were predominantly distal (71%).  
Morphologically, slit-like serration was present in 81%, ectopic crypt formations in 67% and a villous 
component in 47%. These histological features were similar to the 12 “shoulder” lesions. 
Immunohistochemical stains showed absence of β-catenin nuclear expression in 96% of the small 
polyps, retained expression of MLH1 in 100% and Ki-67 positivity restricted to the crypt bases and 
ectopic crypt formations. BRAF and KRAS mutations were identified in 47% and 31% of the polyps 
respectively. Compared with KRAS-mutated polyps, BRAF-mutated polyps were more likely to arise in 
a precursor polyp (82% vs 18%, P < 0.001) and were more likely to have slit-like serrations (100% vs 
73%, P = 0.003). 
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Conclusions:  These morphological, immunohistochemical and molecular findings are similar to what 
has been reported in large TSAs and support the hypothesis that these polyps represent early forms 
of TSA. 
 
Key words:  Colonic polyps; Traditional serrated adenoma; Serrated polyp; Immunohistochemistry; 
BRAF; KRAS 
 
INTRODUCTION 
Serrated colorectal polyps fall into three major categories, namely hyperplastic polyps (HPs), sessile 
serrated polyps (SSPs) and traditional serrated adenomas (TSAs) 1.  Of these only SSPs and TSAs have 
significant malignant potential.  Since the first report of the TSA by Longacre and Fenoglio-Presier 2, 
our understanding of the histology and molecular biology of this rare polyp continues to improve.  
Clinically, TSAs tend to occur in older patients, more commonly in the distal colon and rectum and 
have no significant gender predilection 3-5.  Histologically, the classic TSA is characterised by 
tubulovillous architecture, ectopic crypt formations, slit-like serrations and typical cytology (cells with 
abundant intensely eosinophilic cytoplasm and centrally placed pencillate nuclei).  Although not 
universally recognised, proximal TSAs that are often flat to the endoscopist, have been described 3, 4.  
At a molecular level most TSAs demonstrate activation of the MAP kinase pathway by either KRAS 
mutation in 22-42% or BRAF mutation in 48-67% 4-7. A small proportion are BRAF / KRAS wild-type, 
and these cases segregate best with the KRAS mutated group 3.  WNT pathway activation by PTPRK-
RSPO3 fusions or RNF43 mutations occur in 71% of TSAs 8.  Compared with KRAS-mutated TSAs,  
BRAF-mutated TSAs are more likely to be proximal, to arise in a precursor polyp and to show the CpG 
island methylator phenotype 3, 9.  Regardless of the BRAF or KRAS mutation status, effectively all TSAs 
are mismatch repair proficient, even when they develop high grade dysplasia or malignancy 3.  
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Despite these recent studies, there are still several controversial aspects to TSAs. Proximal and flat 
TSAs remain a matter of contention.  The origin of TSAs is also not clear.  While many BRAF-mutated 
TSAs appear to have their origins in microvesicular hyperplastic polyps or SSPs, this is not universally 
accepted 3, 4, 7, 10.  The origins of KRAS-mutated TSAs remain even more obscure.  In our practice we 
often see large distal TSAs with a central protuberant portion but with a collar (or shoulder) of flat 
TSA at the periphery.  Furthermore, we sometimes see small polyps with features very similar to 
these “shoulder” areas of larger TSAs.  Because there is at present no good alternative, pathologists 
tend to diagnose these as tubular adenomas (albeit odd-looking) or sessile serrated polyps with 
dysplasia (SSPD) when an adjacent SSP component is present.   In the current literature, most 
described TSAs are greater than 10mm in size.  However, TSAs cannot arise as large polyps.  Despite 
this, there are currently no descriptions dedicated to small TSAs.   
 
We hypothesised that early forms of the TSA are recognisable and will have morphological, 
immunohistochemical and molecular features similar to the “shoulder” areas of large TSAs.  Thus the 
aims of the current study were to 1) describe the histology of a series of small polyps that may 
represent early forms of TSAs, 2) to perform a basic immunohistochemical (Ki-67, β-catenin, MLH1) 
and molecular (BRAF and KRAS mutation status) panel on these polyps and to compare to a control 
group of “shoulder areas” of larger TSAs, and 3) to identify clinicopathological differences between 
BRAF- and KRAS-mutated early TSAs.   
 
MATERIALS AND METHODS 
Patients and Samples 
The study group comprised cases collected in a prospective fashion by one of the authors (NW) 
during routine reporting at Envoi Specialist Pathologists in Brisbane, Australia, between January 2014 
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and June 2015.  All cases were reviewed by two other pathologists (MB and CR).  Demographic data 
including age, gender and polyp location were collected from the specimen request form or 
colonoscopy report.  Distal location was assigned for polyps distal to the splenic flexure.  A control 
group comprising the “shoulder” areas of larger TSAs was used for comparison to the study polyps 
and were selected from cases reported in a previous study 3.  Ethics approval for the study was given 
by the QIMR Berghofer Medical Research Institute (P1298). 
 
Histological inclusion criteria 
The study polyps were identified based on size (≤ 10mm) and histological features.  The major 
histological feature was a polyp with TSA-type cytology (eosinophilic cells with centrally placed 
pencillate nuclei) covering the luminal surface.  Any component of villous growth, ectopic crypt 
formations and slit-like serrations were noted, but not required for inclusion.  Villous growth was 
defined as “a free-floating structure with epithelium surrounding a central core of lamina propria”, an 
ectopic crypt formation was defined as “epithelial buds with their bases not in contact with the 
muscularis mucosa” and a slit-like serration as “a narrow slit in the epithelium, similar to those seen in 
normal small bowel” (Figure 1). In cases where there was a clear precursor polyp (e.g. microvesicular 
HP or SSP), the TSA-type cytology was only required to cover the luminal aspect of the discrete TSA-
like area of these polyps. 
 
Immunohistochemistry 
Immunohistochemical stains for MLH1, β-catenin and Ki-67 were performed on the study and control 
polyps as previously described 3. 
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KRAS and BRAF mutation testing 
Testing for KRAS and BRAF mutations was performed on the study and control polyps as previously 
described 3. 
 
Statistical analysis 
Categorical variables were compared using Fisher’s exact test. Continuous variables were compared 
using Student’s t-test. A P-value of < 0.05 was considered significant. 
 
RESULTS 
Clinicopathological features of early traditional serrated adenomas 
Twelve control polyps with an adequate “shoulder” region for comparison were identified from the 
previously published cases 3 (figure 2).  A further 70 polyps met the inclusion criteria for the study 
(figure 3).  The clinicopathological features of the study polyps are presented in table 1.  The mean 
age of the patients was 58 years and the mean polyp size 4.1 mm.  Thirty-eight (54%) of the patients 
were female.  
The histological and immunohistochemical features are described in table 2.  For inclusion, all cases 
required TSA-type cytology covering the luminal aspect of the polyp.  A precursor polyp was identified 
in 34 cases (49%), comprising 13 (19%) microvesicular HPs and 16 (22%) SSPs.  Thirty-three (47%) had 
at least focal villous architecture, 57 (81%) slit-like serrations and 47 (67%) ectopic crypt formations.  
By comparison, the “shoulder” areas of the control cohort showed focal villous change in 3 (25%), slit-
like serrations in 9 (75%) and ectopic crypt formations in 7 (58%).  There was no statistically significant 
difference between the study polyps and the control group (apart from origin in a precursor polyp).   
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Immunohistochemical and molecular features 
The molecular features are described in table 3.  All of the study and control polyps retained nuclear 
staining for MLH1 (mismatch repair proficient) (figure 4D).  Nuclear staining for β-catenin was either 
absent in 67 cases (96%) (figure 4B) or very focal in 3 cases (4%).  The three cases with focal positive 
staining were limited to occasional ectopic crypts, a staining pattern previously described 11.  Ki-67 
showed the same pattern of staining in all study and control cases, with prominent staining in the 
crypts and in ectopic crypt formations but absent staining at the luminal surface (figure 4C).  There 
were no statistically significant differences in the immunohistochemical profiles of the study or 
control polyps. 
Of the 70 study polyps, 33 (47%) were BRAF-mutated, 22 (31%) KRAS-mutated and the remainding 15 
cases were wild-type for both genes.  All 12 of the control polyps were KRAS-mutated. The 
clinicopathological features of the KRAS- versus BRAF-mutated polyps are presented in table 3.  BRAF-
mutated polyps were more likely to arise in a precursor polyp (82% vs 18%, P < 0.001) and were more 
likely to have slit-like serrations than KRAS-mutated polyps (100% vs 73%, P = 0.003) (Table 3). 
 
DISCUSSION 
The TSA has been described as the least common and least understood subtype of the serrated 
polyps 12. Currently it is unusual to diagnose TSA in a polyp under 10mm, but logically early and small 
forms of these polyps must exist.  The aim of this study was to attempt to identify early forms of the 
TSA.  In all, 70 lesions measuring less than 10mm (mean 4.1 mm) were selected.  We reasoned that if 
these early putative TSAs shared morphological and immunohistochemical features with the 
“shoulders” of the larger TSAs, then this would add support to the hypothesis that these are in fact 
small TSAs.  Morphologically, there were no statistically significant differences between the 
“shoulder” areas of large TSAs and the small TSAs of the study group.  Furthermore, the staining 
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patterns for MLH1, Ki-67 and β-catenin were the same between both groups.  In particular all cases 
were mismatch repair proficient, lacked Ki-67 staining at the luminal surface and nearly uniformly 
lacked nuclear staining for β-catenin.   
 
This immunohistochemical pattern is in stark contrast to those described for both SSPDs and 
conventional tubular adenomas, the two main differential diagnoses of early TSA. BRAF-mutated early 
TSAs arising in a precursor microvesicular HP or SSP can be confused with SSPD.  This distinction may 
be clinically relevant. The SSPD is an advanced polyp at a molecular level, with the potential for rapid 
transition to malignancy, in contrast an early TSA is a relatively benign polyp with less immediate 
malignant potential 13.  The dysplastic portion of an SSPD should show overt cytological dysplasia with 
frequent mitoses, including at the luminal surface 14.  This is not a feature of TSA arising in a 
microvesicular HP or SSP.  In addition, SSPD typically show strong staining for Ki-67 at the luminal 
surface in the areas of dysplasia, concordant with the atypical histology 15.  Nuclear β-catenin is also 
relatively common in the dysplastic areas, reflecting abnormalities in the WNT signalling pathway and 
up to 75% lose staining for MLH1 13-15.   KRAS-mutated TSAs rarely arise in a precursor polyp and can 
resemble conventional tubular adenomas 10.  However, tubular adenomas are overtly dysplastic, show 
increased Ki-67 staining at the luminal surface and frequently show nuclear β-catenin staining 16, 17.  
Kim et al. previously reported “tubular adenoma-like” lesions in 18% of TSAs as endoscopically flat-
elevated lesions demonstrating differences in morphology and distribution of Ki-67 to conventional 
tubular adenomas 4.  Furthermore, MAP kinase pathway activation is rare in small tubular adenomas 
17.   
These findings, of striking histological and immunohistochemical similarity between the study polyps 
and the shoulder areas of the larger TSAs and the marked differences to the histology and 
immunohistochemical staining profiles of SSPD and tubular adenomas support the hypothesis that 
these small polyps may represent early forms of the TSA.  However, it must be acknowledged, that in 
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diminutive cases with no precursor polyp, separation from a conventional tubular adenoma in routine 
reporting would be impractical and of limited clinical utility.  Application of immunohistochemistry 
may resolve the uncertainty in most of these cases, but given the limited clinical significance is not 
justified.  However, once slit-like serrations and ectopic crypt formations become identifiable, the 
diagnosis of a TSA should be considered, even if villous change is not apparent. 
 
Of the 70 polyps included in this study, 33 were BRAF-mutated, 22 KRAS-mutated and the remainder 
BRAF / KRAS wild-type.  These ratios are consistent with the published literature 3-5, 9, 11.  The major 
difference between the groups was the very frequent origin of the BRAF-mutated cases in a 
microvesicular HP or SSP.  Previously microvesicular HP or SSP has been associated with 15-57% of 
BRAF-mutated TSAs 3-5.  As might be expected, smaller lesions would be less likely to have overgrown 
their precursor and therefore it is predictable that the association would be higher.  While it is likely 
the remaining polyps overgrew a pre-existing lesion, a rare de novo polyp cannot be excluded.  In 
contrast, a precursor was uncommon amongst KRAS-mutated cases.  However, four did show an 
adjacent goblet cell HP, suggesting that at least some may arise in these polyps.  If KRAS-mutated 
hyperplastic, non-serrated aberrant crypt foci give rise to goblet cell hyperplastic polyps as suggested 
18, then perhaps they can also directly give rise to KRAS-mutated TSAs.   
 
Recently a Japanese group has published a series of polyps designated as “superficially serrated 
adenoma”19.  These polyps appear very similar morphologically to the KRAS-mutated early TSAs in our 
series.  Interestingly, 19 of their 20 cases harboured a KRAS mutation and 18 of the 20 cases showed 
either RSPO3 fusion or over-expression, a feature identified in up to one third of larger TSAs.  In the 
same study, the authors retrospectively identified large TSAs with “superficially serrated adenoma” at 
the edges (very similar in appearances to the “shoulder” areas of our large TSAs) and found RSPO3 
fusion or over-expression in 14 of 15 cases.  Although the final interpretation by the authors was that 
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these represent a separate precursor lesion to the TSA, in our opinion the morphology and molecular 
alterations are more suggestive of an early form of TSA.  Regardless, there is a clear morphological 
and molecular relationship between these lesions and the TSA, quite distinct from the alternative 
diagnoses of goblet cell HP, SSPD or tubular adenoma. 
 
In summary, we reported a series of 70 small polyps that we feel represent the early forms of the 
large well-recognized TSA. At present, many of these polyps would be diagnosed as “odd-looking” 
tubular adenoma (KRAS-mutated forms) or possibly as SSPDs (BRAF-mutated forms).  Careful 
attention to the morphology, in particular, TSA-type cytological changes with concurrent slit-like 
serrations and ectopic crypt formations, can be recognised as clues to the diagnosis.  Prospective 
studies are needed to understand the clinical significance of these lesions. It is currently unknown if a 
three-year colonoscopy surveillance interval, as currently recommended for the usual TSA, is justified 
for early forms of TSA.  
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Table 1. Clinicopathological features of the study and control polyps 
 Study polyps (n=70) Control polyps (n=12) P-value 
Age, years (mean, range) 58 (23-85) 69 (43-84) 0.02 
Female  38 (54%) 9 (75%) 0.22 
Distal location 50 (71%) 12 (100%) N/A 
Size, mm (mean, range) 4.1 (1-10) 23.7 (8-50) N/A
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Table 2. Histological and immunohistochemical features of the study polyps 
 All 
(n=70) 
BRAF
mutated 
(n=33) 
KRAS
mutated 
(n=22) 
Control 
group 
(n=12) 
p-value (BRAF versus 
KRAS mutated) 
Villous component 33 
(47%) 
18 (55%) 10 (45%) 3 (25%) 0.59 
Ectopic crypt 
formations 
47 
(67%) 
29 (88%) 16 (73%) 7 (58%) 0.17 
Slit-like serrations 57 
(81%) 
33 (100%) 16 (73%) 9 (75%) 0.003 
Precursor polyp 34 
(49%) 
27 (82%) 4 (18%) 0 0.0001 
- MVHP 12 
(17%) 
12 (36%) 0 0 0.0016 
- SSA 16 
(23%) 
15 (45%) 0 0 0.0001 
- GCHP 6 (9%) 0 4 (18%) 0 0.0214 
Nuclear β-catenin 
staining 
3 (4%) 0% 3 (14%) 2 (17%) 0.06 
Retained MLH1 
staining 
70 
(100%) 
33 (100%) 22 (100%) 12 (100%) 1.000 
Ki67  Descriptive report only 
MVHP – microvesicular hyperplastic polyp; SSA – sessile serrated adenoma; GCHP – goblet cell 
hyperplastic polyp 
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Table 3. Clinicopathological features of the study by mutation status 
 BRAF mutated polyps (n=33) KRAS mutated polyps (n=22) P-value 
Age, years (mean, range) 56 (36-89) 69 (43-84) 0.02 
Female   18 (54%) 75% 0.22 
Distal location  23 (71%) 100% N/A 
Size, mm (mean, range) 4.8 (2-10) 4.1 (2-8) NA 
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Figure Legends 
Figure 1. (A) Slit-like serration is defined as narrow slit in the epithelium, similar to those seen in 
normal small bowel. (B) Ectopic crypt formations are epithelial buds with their bases not in contact 
with the muscularis mucosa. 
Figure 2. (A and B) Low power examples of the shoulder areas from the large KRAS-mutated control 
traditional serrated adenomas.  (C and D) Medium and high power of the shoulder areas showing 
typical cytology and slit-like serrations, (C) has some rudimentary ectopic crypt formations. 
Figure 3. (A) An early BRAF-mutated traditional serrated adenoma arising in a microvesicular 
hyperplastic polyp.  The central traditional serrated adenoma component has typical cells with 
eosinophilic cytoplasm and bland pencillate nuclei. Some villous change is present and numerous slit-
like serrations are seen.  Occasional ectopic crypt formations are also evident. (B) Another example of 
an early BRAF-mutated traditional serrated adenoma, but this example has a flat surface profile. (C 
and D) Examples of early KRAS-mutated traditional serrated adenomas with typical cytology and slit-
like serrations, (D) has some rudimentary ectopic crypt formations. (E) A particularly villiform early 
BRAF-mutated traditional serrated adenoma.   
Figure 4. (A-D) Haematoxylin and eosin, β-catenin, Ki67 and MLH1 from a KRAS-mutated early 
traditional serrated adenoma. Note the absence of nuclear staining for β-catenin, the lack of surface 
Ki67 proliferative activity and the uniform retained nuclear staining for MLH1. 
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